Insights

Investment Focus Advent Life Sciences specializes in early and mid-stage biotech and healthtech companies across the UK, Europe, and the US, presenting opportunities to partner with innovative firms engaged in cutting-edge drug discovery, biologics, med tech, and vaccines.

Strategic Partnerships The firm actively partners with growth-stage companies, exemplified by recent investments in Artax Biopharma, Moximed, and Proximie, indicating a potential interest in expanding its portfolio through future collaborations and funding opportunities.

Market Positioning As a leading trans-Atlantic venture investor with a proven track record of transforming breakthrough science into approved medicines, Advent Life Sciences is well-positioned to support startups and established companies seeking strategic funding and expertise.

Funding Capacity With a revenue range of 1 million to 10 million and active investments in high-value rounds such as $80 million in Proximie, there are opportunities to offer tailored financial products, co-investments, or consulting services to companies at various funding stages.

Leadership and Growth The recent hiring of Katrine Bosley as CEO, coupled with the firm’s focus on supporting innovative healthcare solutions, highlights its leadership’s commitment to growth and transformational investments, making it an attractive partner for companies seeking strategic scale-up support.

Advent Life Sciences Tech Stack

Advent Life Sciences uses 8 technology products and services including Sucuri, MySQL, imagesLoaded, and more. Explore Advent Life Sciences's tech stack below.

  • Sucuri
    Content Delivery Network
  • MySQL
    Database
  • imagesLoaded
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • X-XSS-Protection
    Security
  • Google Tag Manager
    Tag Management
  • GoDaddy
    Web Hosting
  • Apache HTTP Server
    Web Servers

Media & News

Advent Life Sciences's Email Address Formats

Advent Life Sciences uses at least 1 format(s):
Advent Life Sciences Email FormatsExamplePercentage
First.Last@adventls.comJohn.Doe@adventls.com
45%
First@adventls.comJohn@adventls.com
5%
First.Last@adventls.comJohn.Doe@adventls.com
45%
First@adventls.comJohn@adventls.com
5%

Frequently Asked Questions

Where is Advent Life Sciences's headquarters located?

Minus sign iconPlus sign icon
Advent Life Sciences's main headquarters is located at London, England United Kingdom. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is Advent Life Sciences's official website and social media links?

Minus sign iconPlus sign icon
Advent Life Sciences's official website is adventls.com and has social profiles on LinkedIn.

What is Advent Life Sciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Advent Life Sciences's SIC code is 6371 - Pension, Health, and Welfare Funds NAICS code is 52391 - Miscellaneous Intermediation.

How many employees does Advent Life Sciences have currently?

Minus sign iconPlus sign icon
As of March 2026, Advent Life Sciences has approximately 27 employees across 3 continents, including EuropeAsiaNorth America. Key team members include General Partner: S. J.General Partner: K. M.Owner: P. K.. Explore Advent Life Sciences's employee directory with LeadIQ.

What industry does Advent Life Sciences belong to?

Minus sign iconPlus sign icon
Advent Life Sciences operates in the Venture Capital and Private Equity Principals industry.

What technology does Advent Life Sciences use?

Minus sign iconPlus sign icon
Advent Life Sciences's tech stack includes SucuriMySQLimagesLoadedMicrosoft WordX-XSS-ProtectionGoogle Tag ManagerGoDaddyApache HTTP Server.

What is Advent Life Sciences's email format?

Minus sign iconPlus sign icon
Advent Life Sciences's email format typically follows the pattern of First.Last@adventls.com. Find more Advent Life Sciences email formats with LeadIQ.

When was Advent Life Sciences founded?

Minus sign iconPlus sign icon
Advent Life Sciences was founded in 2005.

Advent Life Sciences

Venture Capital and Private Equity PrincipalsEngland, United Kingdom11-50 Employees

Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and investment success through turning break-through science into approved medicines or medical products.

We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines.

As entrepreneurs and experienced, pragmatic investors, we bring the intellectual capital of our well connected team to support each investment. We work in close alignment with our management teams, and partner with them to realise their vision - achieving superior financial returns by bringing innovation to patients.

The companies in which we have invested since the year 2000 have discovered and developed, fourteen approved medicines and products - to the benefit of patients, physicians and our investors.

Section iconCompany Overview

Headquarters
London, England United Kingdom
SIC Code
6371 - Pension, Health, and Welfare Funds
NAICS Code
52391 - Miscellaneous Intermediation
Founded
2005
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Advent Life Sciences's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Advent Life Sciences's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.